Glenmark Pharma gains on entering into license agreement with Harbour BioMed

06 Aug 2018 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 601.90, up by 5.30 points or 0.89% from its previous closing of Rs. 596.60 on the BSE.

The scrip opened at Rs. 597.00 and has touched a high and low of Rs. 603.55 and Rs. 596.00 respectively.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 698.45 on 04-Aug-2017 and a 52 week low of Rs. 483.60 on 30-May-2018.

Last one week high and low of the scrip stood at Rs. 603.55 and Rs. 567.15 respectively. The current market cap of the company is Rs. 16834.15 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 37.55% and 15.91% respectively.

Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302, Glenmark’s bispecific antibody targeting HER2 and CD3 for the treatment of HER2-positive cancers.

Under the terms of the agreement, Glenmark will receive an upfront payment and is eligible to receive payments for achieving pre-specified development, regulatory and commercialization milestones, as well as tiered royalties on net sales for any approved products from Harbour BioMed. The agreement is potentially worth more than $120 million in addition to royalties for Glenmark.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

2016.90 30.15 (1.52%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×